Last reviewed · How we verify
NCT04753463
Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland
trial testing Survey in SARS-CoV-2 in 126 participants. Completed in 15 April 2021.
28 March 2021
Quick facts
| Lead sponsor | Medical University of Bialystok |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 126 |
| Start date | 15 March 2021 |
| Primary completion | 28 March 2021 |
| Estimated completion | 15 April 2021 |
| Sites | 2 locations across Poland |
Drugs / interventions tested
- Survey
Conditions studied
- SARS-CoV-2 — all drugs for SARS-CoV-2 →
Sponsor
Medical University of Bialystok
Who can join
Adults 25 to 35, any sex, with SARS-CoV-2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of study is to investigate the impact of SARS-CoV-2 on ophthalmology training programs among residents. To the best of our knowledge this study is the first of its kind in Poland. The impact of COVID-19 on ophthalmology training programs is largely unknown as there are only few studies assessing the above issue from the resident's point of view.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04753463
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Survey
Trials testing the same drug.
- NCT07452159 — Diabetes In Asians at Risk in Youth · not yet recruiting
- NCT07294703 — Factors Associated With Breast Cancer Risks and Outcomes · recruiting
- NCT07330739 — Kinesiophobia in Women With Stress Urinary Incontinence · active not recruiting
- NCT07215039 — Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida · enrolling by invitation
- NCT07220096 — Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Pati · recruiting
Other recruiting trials for SARS-CoV-2
Currently open trials in the same condition.
- NCT07266558 — A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without Hig · Phase 4 · recruiting
- NCT06684379 — Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of A · Phase 1, PHASE2 · recruiting
- NCT06585241 — A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations · Phase 4 · recruiting
- NCT05876377 — Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data · active not recruiting
- NCT05799651 — Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults · Phase 1 · active not recruiting
Other Medical University of Bialystok trials
Trials by the same sponsor.
- NCT07496957 — Preserflo MicroShunt Versus Trabeculectomy · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07325552 — iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment · NA · recruiting
- NCT07529145 — Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment · recruiting
- NCT06855979 — The Impact of Dietary Intervention on Oxidative/antioxidant Markers and Gut Microbiota in Athletes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04753463 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Bialystok
- Last refreshed: 28 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04753463.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing